28
Oct
2025

Boehringer Ingelheim Biopharmaceuticals

Exhibitor at CPHI Frankfurt 2025 stand 6.0B66, Contract Manufacturing and Services
About Us

Boehringer Ingelheim BioXcellence™ is the contract manufacturing arm of Boehringer Ingelheim, we have built a reputation as a reliable, world-class partner for biopharmaceuticals manufacturing and global supplies.

With facilities located in the USA, Europe, and Asia, we specialize in mammalian and microbial contract manufacturing, leveraging over 40 years of biotechnology expertise. We offer the full spectrum of services for late-stage products – with a hard-won reputation as a reliable partner accompanying you throughout the lifecycle of your product.

Ou...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • DE
  • 2023
    On CPHI since
  • 5000+
    Employees
Company types
CMO/CDMO
View company profile
Contact info
  • +49 6132 77 2913
  • Website
  • Boehringer Ingelheim Biopharmaceuticals GmbH, Binger Strasse 173, 55216, Ingelheim, Germany
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 6.0B66, Contract Manufacturing and Services

Products Featured at CPHI Frankfurt 2025

  • Downstream Only - Processing for microbial derived proteins

    Product Downstream Only - Processing for microbial derived proteins

    Proven track record in ‘downstream- processing- only’ services Service description: - Intermediate materials, that need to be further purified and/or conjugated - Hormones or other recombinant proteins like virus like particles from inclusion bodies or from biomass - Peptides from inclusion bodies, biom...
  • Early development service for microbial fermentation

    Product Early development service for microbial fermentation

    High throughput process development services for E. coli and yeast based on high degree of automation and digitalization to speed up time to clinic for diverse protein formats e.g., scaffolds, enzymes, pDNA, sub-unit vaccines and antibody fragments. Service description: - Genetic engineering, cell line an...
  • Tech Transfer

    Product Tech Transfer

    Efficient tech transfers from customers or within own global bio-manufacturing network, launch preparation and commercial supply readiness for drug substance and drug product. Service description: - Long-standing track record in product launches - 47 biopharmaceuticals brought to the market - Tailored to...
  • Drug Substance Manufacturing - Mammalian Cell Cultures

    Product Drug Substance Manufacturing - Mammalian Cell Cultures

    • Around 430,000 L total commercial capacity for cell culture  • Manufacturing sites around the globe: Biberach/Germany, Vienna/Austria, Fremont, CA/USA and Shanghai/ China- from 2,000 up to 15,000 L bioreactors  • GMP facilities licensed by EMA, FDA, MHLW and other authorities ...
  • Drug Substance Manufacturing - Microbial Fermentation

    Product Drug Substance Manufacturing - Microbial Fermentation

    12,000 L  commercial manufacturing capacity in multi-licensed facility  Two trains  each with 6,000 L of capacity which can be used with flexible scales
    Large-scale GMP facilities licensed by EMA, FDA & MHLW for clinical and commercial global supplies 
    Protein refol...
  • Aseptic Filling

    Product Aseptic Filling

    • Clinical and commercial capacities and technology for vials  • Formulations for liquids and lyophilizates vials (flexible vial sizes from 2 mL to 100 mL) • Flexible filling volumes for clinical and commercial supply  • Manual and automated visual inspections  • Globally licensed ...